New Approaches to the Treatment of Frontotemporal Dementia

Area of Science:

• Neuroscience
• Genetics
• Neurology

Background:

• Frontotemporal dementia (FTD) encompasses neurodegenerative syndromes affecting behavior, executive function, language, and motor skills.
• Genetic factors account for approximately 20% of FTD cases, with specific mutations identified.
• Frontotemporal lobar degeneration describes the underlying neuropathology of FTD syndromes.

Purpose of the Study:

• To discuss common genetic mutations associated with FTD.
• To review current management strategies for FTD, including pharmacotherapy and non-pharmacological approaches.
• To highlight recent advancements and ongoing clinical trials for FTD treatments.

Main Methods:

• Review of common genetic mutations in FTD.
• Discussion of pharmacotherapy and non-pharmacological interventions for symptom management.
• Overview of current research and clinical trials targeting FTD pathogenetic mechanisms.

Main Results:

• Identified three common genetic mutations responsible for FTD.
• Emphasized that Alzheimer's disease medications are ineffective and potentially harmful for FTD.
• Detailed non-pharmacological management including lifestyle changes, therapies, and support systems.

Conclusions:

• No current disease-modifying treatments exist for FTD, necessitating symptomatic management.
• Advancements in understanding FTD genetics, pathophysiology, and neuroimmunology are paving the way for new treatments.
• Active clinical trials targeting diverse pathogenetic mechanisms offer hope for breakthroughs in FTD management.